Nature wades through the literature on COVID-19 so you don’t have to. 28 April — ‘Dry swabbing’ offers a workaround to test-chemical scarcity Wide-scale genetic testing for SARS-CoV-2 has been hampered, in part, by shortages of the solutions used to store sampling swabs and extract viral RNA from them. To overcome this difficulty, a team...
UNIVERSITY OF HELSINKI An international research team has identified several novel genetic variants associated with plasma levels of lipid species and cardiovascular disease risk in humans. The study demonstrates that genetic studies focusing on circulating molecular lipid levels over traditional lipid measures can help improve cardiovascular risk prediction and treatment. The results of the study...
Many chronic or lifestyle diseases occur without any of the traditional risk factors, precluding the possibility of preventive intervention. The use of proteomic biomarkers is therefore urgently needed to complement and enhance the information available by conventional risk stratification. Blood tests are the most common type of biological tests used in clinical practice and laboratory...
Plasma B cells, which move through the body releasing antibodies, are an important component of the body’s fight against viral infections and other invaders. They are relatively rare, however, and increasing their ranks is a major goal of vaccination. However, scientists do not yet fully understand how precursor cells are selected either to enter the...
